Alpha-话题@MedSci

#Alpha#

25篇内容 | 858人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2048253, encodeId=d4712048253c7, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力, objectType=article, longId=734270, objectId=8ae7e342705f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae7e342705f, replyNumber=0, likeNumber=53, createdTime=2022-11-27, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae7e342705f, moduleTitle=“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae7e342705f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048247, encodeId=4485204824e31, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究, objectType=article, longId=294454, objectId=3f302944546a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f302944546a, replyNumber=0, likeNumber=43, createdTime=2022-02-14, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f302944546a, moduleTitle=J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f302944546a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048254, encodeId=5362204825467, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=AlphaFold是又一个“卡”中国脖子的核心技术？“我们必须从底层技术做起”, objectType=article, longId=735658, objectId=fe3fe3565890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3fe3565890, replyNumber=0, likeNumber=0, createdTime=2022-08-16, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3fe3565890, moduleTitle=AlphaFold是又一个“卡”中国脖子的核心技术？“我们必须从底层技术做起”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3fe3565890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048252, encodeId=57722048252d3, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=怎样推动“从0到1”的原始创新？这个比AlphaFold2更前瞻的研究当年坐足了“冷板凳”, objectType=article, longId=730519, objectId=961fe3051961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=961fe3051961, replyNumber=0, likeNumber=49, createdTime=2023-04-06, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=961fe3051961, moduleTitle=怎样推动“从0到1”的原始创新？这个比AlphaFold2更前瞻的研究当年坐足了“冷板凳”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=961fe3051961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048251, encodeId=10cf20482518f, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=IBD: 血清富含亮氨酸的Alpha-2糖蛋白在评估克罗恩病内镜疾病活动中的准确性, objectType=article, longId=727024, objectId=046fe270245d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=046fe270245d, replyNumber=0, likeNumber=43, createdTime=2022-10-19, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=046fe270245d, moduleTitle=IBD: 血清富含亮氨酸的Alpha-2糖蛋白在评估克罗恩病内镜疾病活动中的准确性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=046fe270245d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048250, encodeId=0b512048250bc, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, objectType=article, longId=300734, objectId=5e00300e34a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e00300e34a5, replyNumber=0, likeNumber=68, createdTime=2022-04-11, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e00300e34a5, moduleTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e00300e34a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048249, encodeId=29802048249cb, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响, objectType=article, longId=299571, objectId=c5b12995e1e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5b12995e1e5, replyNumber=0, likeNumber=49, createdTime=2023-01-04, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5b12995e1e5, moduleTitle=NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5b12995e1e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048248, encodeId=457d2048248bc, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=谷歌AlphaFold破译“上帝密码”，解答困扰人类50年难题, objectType=article, longId=295717, objectId=c101295e175b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c101295e175b, replyNumber=0, likeNumber=41, createdTime=2022-10-04, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c101295e175b, moduleTitle=谷歌AlphaFold破译“上帝密码”，解答困扰人类50年难题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c101295e175b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048246, encodeId=9c2b204824649, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=GUT: Alpha-1抗胰蛋白酶可控制小鼠和人类与酒精相关的肝病, objectType=article, longId=207208, objectId=229720e20813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=229720e20813, replyNumber=0, likeNumber=40, createdTime=2021-08-17, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=229720e20813, moduleTitle=GUT: Alpha-1抗胰蛋白酶可控制小鼠和人类与酒精相关的肝病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=229720e20813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048245, encodeId=06e92048245f8, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=Int J Mol Sci：Alpha-5整合素介导辛伐他汀诱导骨髓间充质干细胞的成骨, objectType=article, longId=159403, objectId=9e2e15940346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e2e15940346, replyNumber=0, likeNumber=54, createdTime=2019-08-06, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e2e15940346, moduleTitle=Int J Mol Sci：Alpha-5整合素介导辛伐他汀诱导骨髓间充质干细胞的成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e2e15940346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048244, encodeId=f4f72048244a5, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=INT J LAB HEMATOL：用于筛查alpha -地中海贫血症的免疫层析条带试验的评价, objectType=article, longId=159354, objectId=6a3a1593548a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a3a1593548a, replyNumber=0, likeNumber=51, createdTime=2019-12-30, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a3a1593548a, moduleTitle=INT J LAB HEMATOL：用于筛查alpha -地中海贫血症的免疫层析条带试验的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a3a1593548a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048243, encodeId=33b3204824315, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=JCC： AlphaE整合素表达在克罗恩病患者回肠中增加并且不受炎症影响, objectType=article, longId=153227, objectId=780915322ee9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780915322ee9, replyNumber=0, likeNumber=46, createdTime=2019-05-02, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780915322ee9, moduleTitle=JCC： AlphaE整合素表达在克罗恩病患者回肠中增加并且不受炎症影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780915322ee9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048242, encodeId=acd52048242a3, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平, objectType=article, longId=140209, objectId=9bfd1402098d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bfd1402098d, replyNumber=0, likeNumber=50, createdTime=2019-05-01, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bfd1402098d, moduleTitle=Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bfd1402098d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048241, encodeId=896c20482416b, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=Alphabet施密特：看好人工智能+医疗, objectType=article, longId=99668, objectId=98a8996685d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98a8996685d, replyNumber=0, likeNumber=54, createdTime=2017-11-09, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98a8996685d, moduleTitle=Alphabet施密特：看好人工智能+医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98a8996685d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048240, encodeId=9284204824094, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=AlphaGo只是开始！深度增强学习前沿算法思想，让通用人工智成为可能, objectType=article, longId=89382, objectId=2c6e89382ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c6e89382ca, replyNumber=0, likeNumber=0, createdTime=2017-11-25, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c6e89382ca, moduleTitle=AlphaGo只是开始！深度增强学习前沿算法思想，让通用人工智成为可能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c6e89382ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048239, encodeId=c1cd204823998, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=虐了世界**围棋手一周的Master，原来就是谷歌的Alphago!, objectType=article, longId=86789, objectId=a48786e89c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a48786e89c1, replyNumber=0, likeNumber=47, createdTime=2017-08-12, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a48786e89c1, moduleTitle=虐了世界**围棋手一周的Master，原来就是谷歌的Alphago!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a48786e89c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048238, encodeId=fce1204823807, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=端午福利：AlphaGo算法清晰的解读, objectType=article, longId=70378, objectId=bef9e0378fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef9e0378fb, replyNumber=0, likeNumber=39, createdTime=2016-12-22, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef9e0378fb, moduleTitle=端午福利：AlphaGo算法清晰的解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bef9e0378fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048234, encodeId=46b5204823496, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=AlphaGo惊天逆转，首胜九段棋手李世石！, objectType=article, longId=64595, objectId=0e186459526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e186459526, replyNumber=0, likeNumber=37, createdTime=2016-11-18, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e186459526, moduleTitle=AlphaGo惊天逆转，首胜九段棋手李世石！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e186459526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048237, encodeId=8fff204823e53, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=AlphaGo进军医疗保健领域, objectType=article, longId=65061, objectId=43f265061a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43f265061a0, replyNumber=0, likeNumber=47, createdTime=2016-04-26, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43f265061a0, moduleTitle=AlphaGo进军医疗保健领域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43f265061a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2048236, encodeId=0a1720482369b, content=<a href='/topic/show?id=20dc234e94' target=_blank style='color:#2F92EE;'>#Alpha#</a>, objectTitle=AlphaGo是什么鬼？告诉你20世纪的十大算法, objectType=article, longId=64646, objectId=817b64646b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b64646b3, replyNumber=0, likeNumber=55, createdTime=2017-02-07, rootId=0, userName=yhy100200, userId=cc52251, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b64646b3, moduleTitle=AlphaGo是什么鬼？告诉你20世纪的十大算法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817b64646b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Alpha

2020-05-29

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

“AlphaFold像地震一样，改变了游戏规则”，如今它开始在基础研究、药物开发上全面发力

2022-11-27

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

J Clin Oncol：Afatinib（阿法替尼）联合Pembrolizumab（帕博利珠单抗）治疗复发或转移性头颈鳞状细胞癌（HNSCC）患者的疗效：ALPHA研究

2022-02-14

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

AlphaFold是又一个“卡”中国脖子的核心技术？“我们必须从底层技术做起”

2022-08-16

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

怎样推动“从0到1”的原始创新？这个比AlphaFold2更前瞻的研究当年坐足了“冷板凳”

2023-04-06

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

IBD: 血清富含亮氨酸的Alpha-2糖蛋白在评估克罗恩病内镜疾病活动中的准确性

2022-10-19

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点

2022-04-11

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响

2023-01-04

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

谷歌AlphaFold破译“上帝密码”，解答困扰人类50年难题

2022-10-04

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

GUT: Alpha-1抗胰蛋白酶可控制小鼠和人类与酒精相关的肝病

2021-08-17

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

Int J Mol Sci：Alpha-5整合素介导辛伐他汀诱导骨髓间充质干细胞的成骨

2019-08-06

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

INT J LAB HEMATOL：用于筛查alpha -地中海贫血症的免疫层析条带试验的评价

2019-12-30

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

JCC： AlphaE整合素表达在克罗恩病患者回肠中增加并且不受炎症影响

2019-05-02

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

Liver Int：PPARalpha/gamma激活剂—saroglitazar可改善NASH小鼠的肝脏功能和组织病理水平

2019-05-01

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

Alphabet施密特：看好人工智能+医疗

2017-11-09

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

AlphaGo只是开始！深度增强学习前沿算法思想，让通用人工智成为可能

2017-11-25

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

虐了世界**围棋手一周的Master，原来就是谷歌的Alphago!

2017-08-12

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

端午福利：AlphaGo算法清晰的解读

2016-12-22

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

AlphaGo惊天逆转，首胜九段棋手李世石！

2016-11-18

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

AlphaGo进军医疗保健领域

2016-04-26

yhy100200 (审核中...)

前往app查看评论内容

#Alpha#

AlphaGo是什么鬼？告诉你20世纪的十大算法

2017-02-07

科室
- - 订阅+
  - 更多科室
工具
服务